Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Cited by (1,003)

Items 201–300 of 1,003

1. Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories
   Lene Holm Harritshøj, Mikkel Gybel‐Brask, Shoaib Afzal, Pia R. Kamstrup, Charlotte Sværke Jørgensen, Marianne Kragh Thomsen, Linda Maria Hilsted, Lennart Jan Friis-Hansen, Pal Bela Szecsi, Lise Pedersen et al. · 2021 · Journal of Clinical Microbiology
2. Magnetic-Nanosensor-Based Virus and Pathogen Detection Strategies before and during COVID-19
   Kai Wu, Renata Saha, Diqing Su, Venkatramana Divana Krishna, Jinming Liu, Maxim C.‐J. Cheeran, Jian-Ping Wang · 2020 · ACS Applied Nano Materials
3. Classification and specific primer design for accurate detection of SARS-CoV-2 using deep learning
   Alejandro Lopez‐Rincon, Alberto Paolo Tonda, Lucero Mendoza‐Maldonado, Daphne G.J.C. Mulders, Richard Molenkamp, Carmina Angelica Perez-Romero, Eric Claassen, Johan Garssen, Aletta D. Kraneveld · 2021 · Scientific Reports
4. Longitudinal Change of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Patients with Coronavirus Disease 2019
   Guoxin Zhang, Shuke Nie, Zhaohui Zhang, Zhentao Zhang · 2020 · The Journal of Infectious Diseases
5. SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus
   M. Dogan, L. Kozhaya, L. Placek, Courtney Gunter, Mesut Yi̇ği̇t, R. Hardy, Matthew Plassmeyer, Paige Coatney, Kimberleigh Lillard, Z. Bukhari et al. · 2021 · Communications Biology
6. SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
   Peluso, Michael J., Takahashi, Saki, Hakim, Jill, Kelly, J. Daniel, Torres, Leonel, Iyer, Nikita S., Turcios, Keirstinne, Janson, Owen, Munter, Sadie E., Thanh, Cassandra et al. · 2021 · Science Advances
7. Point-of-Use Rapid Detection of SARS-CoV-2: Nanotechnology-Enabled Solutions for the COVID-19 Pandemic
   Navid Rabiee, Mojtaba Bagherzadeh, Amir Ghasemi, Hossein Zare, Sepideh Ahmadi, Yousef Fatahi, Rassoul Dinarvand, Mohammad Rabiee, Seeram Ramakrishna, Mohammadreza Shokouhimehr et al. · 2020 · International Journal of Molecular Sciences
8. Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients
   Srinivasa Reddy Bonam, Srini V. Kaveri, Anavaj Sakuntabhai, Laurent Gilardin, Jagadeesh Bayry · 2020 · Cell Reports Medicine
9. Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation
   Victoria Higgins, Anselmo Fabros, Vathany Kulasingam · 2021 · Journal of Clinical Microbiology
10. Emerging point-of-care biosensors for rapid diagnosis of COVID-19: current progress, challenges, and future prospects
    Yousef Rasmi, Xiaokang Li, Johra Khan, Tuğba Özer, Jane Ru Choi · 2021 · Analytical and Bioanalytical Chemistry
11. Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2
    Jéromine Klingler, Svenja Weiß, Vincenza Itri, Xiaomei Liu, Kasopefoluwa Y. Oguntuyo, Christian S. Stevens, Satoshi Ikegame, Chuan-Tien Hung, Gospel M Enyindah-Asonye, Fatima Amanat et al. · 2020 · The Journal of Infectious Diseases
12. The serum metabolome of COVID-19 patients is distinctive and predictive
    Ding Shi, Yan Ren, Longxian Lv, Huiyong Jiang, Yingfeng Lu, Jifang Sheng, Jiaojiao Xie, Wenrui Wu, Jiafeng Xia, Kaijin Xu et al. · 2021 · Metabolism
13. New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic
    Heli Salmi, Santtu Heinonen, Johanna Hästbacka, Mitja Lääperi, Paula Rautiainen, Päivi Johanna Miettinen, Olli P. Vapalahti, Jussi Hepojoki, Mikael Knip · 2021 · Archives of Disease in Childhood
14. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity
    Kathleen M. McAndrews, Dara P. Dowlatshahi, Jianli Dai, Lisa M. Becker, Janine Hensel, Laura M. Snowden, Jennifer M. Leveille, Michael R. Brunner, Kylie W. Holden, Nikolas S. Hopkins et al. · 2020 · JCI Insight
15. COVID-19 infection in kidney transplant recipients at the epicenter of pandemics
    Yorg Azzi, Michael K. Parides, Omar Alani, Pablo Loarte-Campos, Rachel M. Bartash, Stefanie K. Forest, Adriana I. Colovai, Maria Ajaimy, Luz E. Liriano-Ward, Cindy T. Pynadath et al. · 2020 · Kidney International
16. Convalescent Plasma Therapy for COVID-19: State of the Art
    Daniele Focosi, Arthur O. Anderson, Julian Wei-Tze Tang, Marco Tuccori · 2020 · Clinical Microbiology Reviews
17. Clinical testing for COVID-19
    Stephanie Ward, Andrew Lindsley, Josh Courter, Amal Assa’ad · 2020 · Journal of Allergy and Clinical Immunology
18. HLA, Immune Response, and Susceptibility to COVID-19
    Fataneh Tavasolian, Mohsen Rashidi, Gholamreza Hatam, Marjan Jeddi, Ahmad Zavaran Hosseini, Sayed Hussain Mosawi, Elham Abdollahi, Robert Davies Inman · 2021 · Frontiers in Immunology
19. Capacitive Aptasensor Coupled with Microfluidic Enrichment for Real-Time Detection of Trace SARS-CoV-2 Nucleocapsid Protein
    Haochen Qi, Hu Zhi, Zhongliang Yang, Jian Zhang, Jie Jayne Wu, Cheng Cheng, Chunchang Wang, Lei Zheng · 2022 · Analytical Chemistry
20. Retest positive for SARS‐CoV‐2 RNA of “recovered” patients with COVID‐19: Persistence, sampling issues, or re‐infection?
    Hanyujie Kang, Yishan Wang, Zhaohui Tong, Xuefeng Liu · 2020 · Journal of Medical Virology
21. Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
    Savannah E. Butler, Andrew R. Crowley, Harini Natarajan, Shiwei Xu, Joshua A. Weiner, Carly A. Bobak, Daniel E. Mattox, Jiwon Lee, Wendy Wieland‐Alter, Ruth I. Connor et al. · 2021 · Frontiers in Immunology
22. Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients
    Yuan-Ling Yu, Meiyu Wang, Xiao-Ai Zhang, Shu-Fen Li, Qing-yue Lu, Hao-Long Zeng, Hongyan Hou, Hao Li, Meng-Yi Zhang, F. Jiang et al. · 2021 · Signal Transduction and Targeted Therapy
23. Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients
    Jae‐Hoon Ko, Eun‐Jeong Joo, Su‐Jin Park, Jin Yang Baek, Won Duk Kim, Jaehwan Jee, Chul‐Joong Kim, Chul Jeong, Yae-Jean Kim, Hye Jin Shon et al. · 2020 · Journal of Clinical Medicine
24. Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma
    Margot Egger, Christian Bundschuh, Kurt Wiesinger, Christian Gabriel, Martin Clodi, Thomas Mueller, Benjamin Dieplinger · 2020 · Clinica Chimica Acta
25. Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
    Matthew S Buckland, James Benjamin Galloway, Caoimhe Nic Fhogartaigh, Luke W. Meredith, Nicholas M. Provine, Stuart Bloor, Ane Ogbe, Wioleta Milena Zelek, Anna Smielewska, Anna Yakovleva et al. · 2020 · Nature Communications
26. Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies
    Yuwen Zhou, Yao Xie, Liansha Tang, Dan Pu, Yajuan Zhu, Jiyan Liu, Xuelei Ma · 2021 · Signal Transduction and Targeted Therapy
27. Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis
    Dong Huang, He Yu, Ting Wang, Huan Yang, R. Yao, Zong-An Liang · 2020 · Journal of Medical Virology
28. Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2
    Alex Renn, Ying Fu, Xin Hu, Matthew D. Hall, Anton M. Simeonov · 2020 · Trends in Pharmacological Sciences
29. A comparative review of immunoassays for COVID-19 detection
    Elham Mohit, Zahra Rostami, Hossein Vahidi · 2021 · Expert Review of Clinical Immunology
30. The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays
    Maria Giaele Infantino, Massimo Pieri, Marzia Nuccetelli, Valentina Grossi, Barbara Lari, Flaminia Tomassetti, Graziella Calugi, Silvia Pancani, Maurizio Benucci, Patrizia Casprini et al. · 2021 · International Immunopharmacology
31. Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays
    Giuseppe Lippi, Gian Luca Salvagno, Manuela Pegoraro, Valentina Militello, Cecilia Caloi, Angelo Peretti, Stefania Gaino, Antonella Bassi, Chiara Bovo, Giuliana Lo Cascio · 2020 · Clinical Chemistry and Laboratory Medicine (CCLM)
32. Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19
    Kazuo Imai, Sakiko Tabata, Mayu Ikeda, Sakiko Noguchi, Yutaro Kitagawa, Masaru Matuoka, Kazuyasu Miyoshi, Norihito Tarumoto, Jun Sakai, Toshimitsu Ito et al. · 2020 · Journal of Clinical Virology
33. High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19
    David Schub, Verena Klemis, Sophie Schneitler, Janine Mihm, Philipp Moritz Lepper, Heinrike Wilkens, Robert Bals, Hermann Eichler, Barbara Christine Gärtner, Sören L. Becker et al. · 2020 · JCI Insight
34. Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
    Fafi-Kremer, Samira, Bruel, Timothée, Madec, Yoann, Grant, Rebecca, Tondeur, Laura, Grzelak, Ludivine, Staropoli, Isabelle, Anna, François, Souque, Philippe, Fernandes-Pellerin, Sandrine et al. · 2020 · eBioMedicine
35. Saliva—Friend and Foe in the COVID-19 Outbreak
    Pingping Han, Sašo Ivanovski · 2020 · Diagnostics
36. A point-of-care selenium nanoparticle-based test for the combined detection of anti-SARS-CoV-2 IgM and IgG in human serum and blood
    Zhizeng Wang, Zhi Jian Zheng, Hangzhan Hu, Qianwen Zhou, Wei Yong Liu, Xiaoquan Li, Zhigang Liu, Yaohui Wang, Yuan-fang Ma A · 2020 · Lab on a Chip
37. Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity
    Jorge Carrillo, Nuria Izquierdo‐Useros, Carlos Ávila‐Nieto, Edwards Pradenas, Bonaventura Clotet, Julià Blanco · 2020 · Biochemical and Biophysical Research Communications
38. Antibody Response After SARS-CoV-2 Infection and Implications for Immunity
    Irina Arkhipova-Jenkins, Mark Helfand, Charlotte Armstrong, Emily G. Gean, Joanna Anderson, Robin A. Paynter, Katherine Mackey · 2021 · Annals of Internal Medicine
39. Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays
    Katharine Uhteg, Junko Jarrett, Mahmia Richards, Craig Howard, Elizabeth Morehead, Melissa Geahr, Linda Gluck, Ann Hanlon, Brandon C. Ellis, Harsimar B. Kaur et al. · 2020 · Journal of Clinical Virology
40. Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome
    Maria Fernanda Bádue Pereira, Nadia Litvinov, Sylvia Costa Lima Farhat, Adriana Pasmanik Eisencraft, Maria Augusta Bento Cicaroni Gibelli, Werther Brunow de Carvalho, Vinicius Rodrigues Fernandes, Thais Toledo Fink, Juliana Valéria de Souza Framil, Karine Vusberg Galleti et al. · 2020 · Clinics
41. Dysregulated transcriptional responses to SARS-CoV-2 in the periphery
    Micah T. McClain, Florica J. Constantine, Ricardo Henao, Yiling Liu, Ephraim L. Tsalik, Thomas W. Burke, Julie M. Steinbrink, Elizabeth Petzold, Bradly P. Nicholson, Robert J. Rolfe et al. · 2021 · Nature Communications
42. Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation
    Bo Yuan, Hanqing Liu, Zhengrong Yang, Yongxin Chen, Zhi‐Yong Liu, Kai Zhang, Cheng Wang, Weixin Li, Yawen An, Jianchun Wang et al. · 2020 · Scientific Reports
43. The unique features of SARS‐CoV‐2 transmission: Comparison with SARS‐CoV, MERS‐CoV and 2009 H1N1 pandemic influenza virus
    Zhonglan Wu, David Harrich, Zhongyang Li, Dongsheng Hu, Dongsheng Li · 2020 · Reviews in Medical Virology
44. Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
    Edwards Pradenas, Benjamin Trinité, Víctor Urrea, Sílvia Marfil, Carlos Ávila‐Nieto, Maria Luisa Rodrı́guez de la Concepción, Ferran Tarrés-Freixas, Silvia Pérez-Yanes, Carla Rovirosa, Erola Ainsua‐Enrich et al. · 2021 · Med
45. An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
    Cielo García Montero, Oscar Fraile‐Μartinez, Coral Bravo, Diego Torres‐Carranza, Lara Sánchez‐Trujillo, Ana Maria Gomez-Lahoz, Luis G. Guijarro, Natalio García‐Honduvilla, Ángel Asúnsolo, Julia Buján et al. · 2021 · Vaccines
46. Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay
    Elena Riester, Peter Findeisen, Johannes Kolja Hegel, Michael Kabesch, Andreas Ambrosch, Christopher M. Rank, Florina Pessl, Tina Laengin, Christoph Niederhauser · 2021 · Journal of Virological Methods
47. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines
    Hsin‐I Shih, Chi-Jung Wu, Yi‐Fang Tu, Chia‐Yu Chi · 2020 · Biomedical Journal
48. COVID-19: from epidemiology to treatment
    Juan Manuel Pericàs, Marta Hernández‐Meneses, Timothy Patrick Sheahan, Eduard Quintana, Juan Ambrosioni, Elena Sandoval, Carlos Falces, María Ángeles Marcos, Montserrat Tuset, Anna Vilella et al. · 2020 · European Heart Journal
49. Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19—Nashville, Tennessee
    William B. Stubblefield, H. Keipp Talbot, Leora R. Feldstein, Mark W. Tenforde, Mohammed Ata Ur Rasheed, Lisa A. Mills, Sandra N. Lester, Brandi D. Freeman, Natalie J. Thornburg, Ian D. Jones et al. · 2020 · Clinical Infectious Diseases
50. Global attitudes in the management of acute appendicitis during COVID-19 pandemic: ACIE Appy Study
    Benedetto Ielpo, Mauro Podda, Gianluca Pellino, Francesco Pata, Riccardo R.C. Caruso, Gianpiero G Gravante, Salomone Di Saverio, ACIE Appy Study Collaborative · 2020 · British journal of surgery
51. Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients
    Claudia Alteri, Valeria Cento, Maria Antonello, Luna Colagrossi, Marco Merli, Nicola Ughi, Silvia Renica, Elisa Matarazzo, Federica Di Ruscio, Livia Tartaglione et al. · 2020 · PLoS ONE
52. Lack of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Large Cohort of Previously Infected Persons
    Lyle R. Petersen, Samira Sami, Nga Vuong, Preeti Pathela, Don Weiss, Beth Maldin Morgenthau, Rebecca A. Henseler, Demetre Daskalakis, Jenny G. Atas, Anita K. Patel et al. · 2020 · Clinical Infectious Diseases
53. Benefits and limitations of serological assays in COVID-19 infection
    Zeeshan Sidiq, Mahmud Hanif, Kaushal Kumar Dwivedi, K.K. Chopra · 2020 · Indian Journal of Tuberculosis
54. Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings
    Suzanne Pickering, Gilberto Betancor, Rui Pedro Galão, Blair Merrick, Adrian W. Signell, Harry Wilson, Mark Tan Kia Ik, Jeffrey Seow, Carl Graham, Sam Acors et al. · 2020 · PLoS Pathogens
55. SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals
    Cecilie Bo Hansen, Ida Jarlhelt, Laura Pérez‐Alós, Lone Hummelshøj Landsy, Mette Loftager, Anne Rosbjerg, Charlotte Helgstrand, Jais Rose Bjelke, Thomas Egebjerg, Joseph G. Jardine et al. · 2020 · The Journal of Immunology
56. Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art
    Gabriel Siracusano, Claudia Pastori, Lucia Lopalco · 2020 · Frontiers in Immunology
57. Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC)
    Raghav Bhatia, Sarandeep Marwaha, Aneil Malhotra, Zafar Iqbal, Christopher Hughes, Mats Börjesson, Josef Niebauer, Antonio Pelliccia, Christian Marc Schmied, Luis Serratosa et al. · 2020 · European Journal of Preventive Cardiology
58. On the Challenges for the Diagnosis of SARS-CoV-2 Based on a Review of Current Methodologies
    Isabela A. Mattioli, Ayaz Hassan, Osvaldo N. Oliveira, Frank N. Crespilho · 2020 · ACS Sensors
59. ASSURED‐compliant point‐of‐care diagnostics for the detection of human viral infections
    Mahdi Naseri, Zyta Maria Ziora, George Philip Simon, Warren Jeffrey Batchelor · 2021 · Reviews in Medical Virology
60. The role of IgA in COVID-19
    Yinxia Chao, Olaf Rötzschke, Eng‐King Tan · 2020 · Brain Behavior and Immunity
61. A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients
    Yuxin Chen, Xin Tong, Yang Li, Bin Gu, Jiawei Yan, Yong Liu, Han Shen, Rui Huang, Chao Wu · 2020 · PLoS Pathogens
62. Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review
    David Jarrom, Lauren Elston, Jennifer Washington, Matthew Prettyjohns, Kimberley Cann, Susan Myles, Peter Groves · 2020 · BMJ Evidence-Based Medicine
63. Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates
    Tiancheng Liu, Jessica Hsiung, Su Zhao, Jessica Kost, Deepika Sreedhar, Carl Veith Hanson, Kjerstie Olson, Douglas Keare, Shin Ting Chang, Kevin P. Bliden et al. · 2020 · Nature Biomedical Engineering
64. SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms
    Janeri Fröberg, Joshua Gillard, Ria L. A. Philipsen, Kjerstin H. W. Lanke, Joyce Rust, Diana van Tuijl, Karina Teelen, Teun Bousema, Elles R. Simonetti, Christa E. van der Gaast‐de Jongh et al. · 2021 · Nature Communications
65. SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity
    Benjamin Trinité, Ferran Tarrés-Freixas, Jordi Rodon, Edwards Pradenas, Víctor Urrea, Sílvia Marfil, Maria Luisa Rodrı́guez de la Concepción, Carlos Ávila‐Nieto, Carmen Aguilar‐Gurrieri, Ana Barajas et al. · 2021 · Scientific Reports
66. Evaluation and Comparison of Serological Methods for COVID-19 Diagnosis
    Fanwu Gong, Hua-xing Wei, Qiangsheng Li, Liu Liu, Bofeng Li · 2021 · Frontiers in Molecular Biosciences
67. SARS-CoV-2 Antiviral Therapy
    Kaiming Tao, Philip L. Tzou, Janin Nouhin, Hector Fabio Bonilla, Prasanna Jagannathan, Robert W. Shafer · 2021 · Clinical Microbiology Reviews
68. Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays?
    Mario Plebani, Andrea Padoan, Davide Negrini, Benedetta Carpinteri, Laura Sciacovelli · 2020 · Clinica Chimica Acta
69. Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes
    Asaf Poran, Dewi Harjanto, Matthew Malloy, Christina M. Arieta, Daniel A. Rothenberg, Divya Lenkala, Marit M. van Buuren, Terri A. Addona, Michael S. Rooney, Lakshmi Srinivasan et al. · 2020 · Genome Medicine
70. Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia
    Lindsey Elizabeth Roeker, David A. Knorr, Melissa S. Pessin, Lakshmi V. Ramanathan, Meghan C. Thompson, Lori Ann Leslie, Andrew David Zelenetz, Anthony R. Mato · 2020 · Leukemia
71. Highly Sensitive and Specific Multiplex Antibody Assays To Quantify Immunoglobulins M, A, and G against SARS-CoV-2 Antigens
    Carlota Dobaño, Marta Vidal, Rebeca Santano, Alfons Jiménez, Jordi Chi, Diana Barrios, Gemma Ruiz‐Olalla, Natalia Rodrigo Melero, Carlo Carolis, Daniel Parras et al. · 2020 · Journal of Clinical Microbiology
72. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions
    Wajihul Hasan Khan, Zohra Hashmi, Aditya Goel, Razi Ahmad, K. Gupta, Nida Khan, Iqbal Alam, Faheem Ahmed, Mairaj Ahmed Ansari · 2021 · Frontiers in Cellular and Infection Microbiology
73. Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital
    David S. Y. Ong, Stijn J. de Man, F.A. Lindeboom, Johannes G.M. Koeleman · 2020 · Clinical Microbiology and Infection
74. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
    Yun-yu Zhang, Bi-ru Li, Botao Ning · 2020 · Frontiers in Immunology
75. SARS-CoV-2 in first trimester pregnancy: a cohort study
    Nina la Cour Freiesleben, Pia Egerup, Kathrine Vauvert Römmelmayer Hviid, Elin Rosenbek Severinsen, Astrid Marie Kolte, David Westergaard, Line Fich Olsen, Lisbeth Prætorius, Anne Zedeler, A.-M. H. Christiansen et al. · 2020 · Human Reproduction
76. Estimating the Extent of True Asymptomatic COVID-19 and Its Potential for Community Transmission: Systematic Review and Meta-Analysis
    Oyungerel Byambasuren, Magnolia Cardona, Katy Bell, Justin Michael Clark, Mary‐Louise McLaws, Paul Glasziou · 2020 · SSRN Electronic Journal
77. SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak
    Valenti, Luca, Bergna, Annalisa, Pelusi, Serena, Facciotti, Federica, Lai, Alessia, Tarkowski, Maciej, Berzuini, Alessandra, Caprioli, Flavio, Santoro, Luigi, Baselli, Guido et al. · 2020
78. Nanocarrier vaccines for SARS-CoV-2
    Jatin Machhi, Farah Shahjin, Srijanee Das, Milankumar Patel, M. M. Abdelmoaty, Jacob D. Cohen, P. Singh, Ashish Baldi, N. Bajwa, Raj Kumar et al. · 2021 · Advanced Drug Delivery Reviews
79. Antibody detection assays for COVID‐19 diagnosis: an early overview
    Sarfaraz Ahmad Ejazi, Sneha Ghosh, Nahid Ali · 2020 · Immunology and Cell Biology
80. COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain
    Massimiliano Secchi, Elena Bazzigaluppi, Cristina Brigatti, Ilaria Marzinotto, Cristina Tresoldi, Patrizia Querini Rovere, Andrea Poli, Antonella Castagna, Gabriella Scarlatti, Alberto Zangrillo et al. · 2020 · Journal of Clinical Investigation
81. Self-supervised contrastive learning for integrative single cell RNA-seq data analysis
    Wenkai Han, Yuqi Cheng, Jiayang Chen, Huawen Zhong, Zhihang Hu, Siyuan Chen, Licheng Zong, Liang Hong, Ting‐Fung Chan, Irwin King et al. · 2022 · Briefings in Bioinformatics
82. Seroepidemiologic Study Designs for Determining SARS-COV-2 Transmission and Immunity
    Hannah Clapham, James A. Hay, Isobel Routledge, Saki Takahashi, Marc Choisy, Derek A. T. Cummings, Bryan Thomas Grenfell, Charlotte Jessica E. Metcalf, Michael Joseph Mina, Isabel Rodríguez-Barraquer et al. · 2020 · Emerging infectious diseases
83. Suboptimal Biological Sampling as a Probable Cause of False-Negative COVID-19 Diagnostic Test Results
    Natalie N. Kinloch, Gordon Ritchie, Chanson J. Brumme, Winnie W. Y. Dong, Weiyan Dong, Tanya Lawson, Richard Brad Jones, Julio S. G. Montaner, Victor C. M. Leung, Marc G. Romney et al. · 2020 · The Journal of Infectious Diseases
84. Fighting COVID-19: Integrated Micro- and Nanosystems for Viral Infection Diagnostics
    Zhen Qin, Ran Peng, Ilina Kolker Baravik, Xinyu Liu · 2020 · Matter
85. COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
    Naveen L. Pereira, Ferhaan Ahmad, Mirnela Byku, Nathan W. Cummins, Alanna A. Morris, ANJALI TIKU OWENS, Sony Tuteja, Sharon Cresci · 2020 · Mayo Clinic Proceedings
86. Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
    Édouard Tuaillon, Karine Bolloré, Amandine Pisoni, Ségolène Debiesse, Constance Renault, S Marie, Soraya Groc, C�mara Niels, Nathalie Pansu, Anne‐Marie Dupuy et al. · 2020 · Journal of Infection
87. A study of breastfeeding practices, SARS-CoV-2 and its antibodies in the breast milk of mothers confirmed with COVID-19
    Sicong Peng, Huaping Zhu, Lixia Yang, Li Cao, Xiaona Huang, Michelle M. Dynes, Anuradha Narayan, Jianbo Xia, Yang Chen, Pei Cong Zhang et al. · 2020 · The Lancet Regional Health - Western Pacific
88. CRISPR-based tools: Alternative methods for the diagnosis of COVID-19
    Fahreddin Palaz, Ali Kerem Kalkan, Abdullah Tozluyurt, Mehmet Özsöz · 2021 · Clinical Biochemistry
89. Research fatigue in COVID-19 pandemic and post-disaster research: causes, consequences and recommendations
    Sonny S. Patel, Rebecca Webster, Neil L. Greenberg, Dale Weston, Samantha K. Brooks · 2020 · Disaster Prevention and Management An International Journal
90. Immunologic Testing for SARS-CoV-2 Infection from the Antigen Perspective
    Dandan Li, Jinming Li · 2020 · Journal of Clinical Microbiology
91. Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study
    Zhen Zhang, Qifang Bi, Shisong Fang, Lan Wei, Xin Wang, Jianfan He, Yongsheng Wu, Xiaojian Liu, Wei Gao, Renli Zhang et al. · 2021 · The Lancet Microbe
92. Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study
    Kelvin Kai‐Wang To, Vincent Chi‐Chung Cheng, Jian‐Piao Cai, Kwok‐Hung Chan, Lin‐Lei Chen, L S Wong, Charlotte Yee-Ki Choi, Carol Ho-Yan Fong, Anthony Chin‐Ki Ng, Lu Lu et al. · 2020 · The Lancet Microbe
93. Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and sero-surveillance
    Brandi D. Freeman, Sandra N. Lester, Lisa A. Mills, Mohammad Ata Ur Rasheed, Stefany Moye, Olubukola M. Abiona, Geoffrey B. Hutchinson, Maria Eugenia Morales-Betoulle, Inna Krapinunaya, Ardith Gibbons et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
94. The dynamic changes of serum IgM and IgG against SARS‐CoV‐2 in patients with COVID‐19
    Wei Zhou, Xiaomao Xu, Zhigang Chang, He Wang, Xuefeng Zhong, Xunliang Tong, Taotao Liu, Yanming Li · 2020 · Journal of Medical Virology
95. Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19
    Severino Jefferson Ribeiro da Silva, Caroline Targino Alves da Silva, Klarissa Miranda Guarines, Renata Pessôa Germano Mendes, Keith Pardee, Alain Kohl, Lindomar Pena · 2020 · ACS Infectious Diseases
96. Dysregulated adaptive immune response contributes to severe COVID-19
    Kuai Yu, 吴永坚, Jingjing He, Xuefei Liu, Bo Wei, Wen Wen, Xiaofeng Wen, Wenxiong Xu, Xingjun Dong, Yue Yan et al. · 2020 · Cell Research
97. Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset
    Benny Borremans, Amandine Gamble, Katherine C. Prager, Sarah K. Helman, Abby M. McClain, Caitlin Cox, Van Savage, James O. Lloyd‐Smith · 2020 · eLife
98. Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease 2019: Serologic Testing
    Mary K. Hayden, Ibrahim K El Mikati, Kimberly E. Hanson, Janet A. Englund, Romney M. Humphries, Francesca Lee, Mark B Loeb, Daniel J. Morgan, Robin Patel, Omar Al Ta’ani et al. · 2024 · Clinical Infectious Diseases
99. Intrauterine vertical transmission of SARS‐CoV‐2: what we know so far
    Chen Wang, Y.‐H. Zhou, Huixia Yang, Liona C. Poon · 2020 · Ultrasound in Obstetrics and Gynecology
100. Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection
     Maria Martínez Serrano, David Navalpotro Rodríguez, Nuria Tormo, Roberto Olmos Arenas, Marta Moreno-Córdoba, M. Dolores Ocete Mochón, Concepción Gimeno Cardona · 2020 · Journal of Clinical Virology